Clinical trials
Withdrawn Phase 1/2 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Intima Bioscience, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 7 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 4 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Adenocarcinoma | 1 |
| Lung Diseases | 1 |
| Neoplasm Metastasis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.